Similar Articles
1611 Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma
1612 Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus
1613 New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples
1614 Antitumor activity of an hTERT promoter-regulated tumor-selective oncolytic adenovirus in human hepatocellular carcinoma
1615 Hepatocellular carcinoma prevention: A worldwide emergence between the opulence of developed countries and the economic constraints of developing nations
1616 Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: A multicenter study of 412 patients
1617 Efficacy and safety of thalidomide in patients with hepatocellular carcinoma
1618 Milan criteria are useful predictors for favorable outcomes in hepatocellular carcinoma patients undergoing liver transplantation after transarterial chemoembolization
1619 Precore/basal core promoter mutants and hepatitis B viral DNA levels as predictors for liver deaths and hepatocellular carcinoma
1620 Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA